Levodopa Dose-Limiting Dyskinesias in Treatment of Segawa Disease
Researchers at the University of Cordoba, and other centers in Spain, Germany and New York report an atypical phenotype of persistent, low-dose levodopa treatment-limiting dyskinesias in 2 members of a family (female child aged 13 years and mother) with prominent brachial dystonia and a novel GCH1 m...
Saved in:
Main Author: | J Gordon Millichap (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2012-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Levodopa-induced Dyskinesias in Parkinson's Disease: Current Knowledge and Future Scenarios
by: Francesca Morgante
Published: (2015) -
Analysis of Genetic and Non-genetic Predictors of Levodopa Induced Dyskinesia in Parkinson's Disease
by: Alfonsina Tirozzi, et al.
Published: (2021) -
Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia
by: Pedro eBarroso Chinea, et al.
Published: (2010) -
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
by: Sharma VD, et al.
Published: (2018) -
Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model
by: Pegah Ashrafi, et al.
Published: (2022)